The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Elevated Serum Level of Anti-Mullerian Hormone in Patients with Polycystic Ovary Syndrome: Relationship to the Ovarian Follicle Excess and to the Follicular Arrest
Abstract
The serum level of anti-Mullerian hormone (AMH), a product from granulosa cells involved in follicle growth, has been shown to correlate tightly with the small antral follicle number (FN) at ultrasonography (U/S) in women who do not have polycystic ovary syndrome (PCOS). Because PCOS is associated with a 2- to 3-fold increase in growing FN, we investigated whether an increased AMH serum level correlates to other hormonal and/or U/S features of PCOS. Serum AMH has been assayed in 104 women (59 symptomatic PCOS, 45 controls) between d 2 and 7 after the last either spontaneous or progestin-induced (in PCOS) menstrual period. Mean serum AMH level was markedly increased in the PCOS group (47.1 +/- 22.9 vs. 20.8 +/- 11.6 pmol/liter in controls; P < 0.0001), an increase in the same order of magnitude as the one of the FN in the 2- to 5-mm range at U/S (12.8 +/- 8.3 vs. 4.8 +/- 1.9; P < 0.0001, respectively). The ratio AMH/FN was similar between the two groups (4.8 +/- 3.4 vs. 4.8 +/- 2.9; P = 0.55). By simple regression, both in PCOS and controls, the AMH level was positively related to the 2- to 5-mm FN at U/S (P < 0.0001 and P < 0.03, respectively), but not to the 6- to 9-mm FN, and was negatively correlated to the serum FSH level (P < 0.02 and P < 0.04, respectively). AMH was also positively related to the serum testosterone and androstenedione levels, in PCOS exclusively (P < 0.0005 and <0.002, respectively). No relationship was found between AMH and age, serum estradiol, inhibin B, and LH levels in both groups. After multiple regression only the 2- to 5-mm FN remained significantly related to AMH in PCOS whereas testosterone, androstenedione, and FSH were no longer. In conclusion, the assay of the serum AMH may represent an important breakthrough in the diagnosis and in the understanding of PCOS. Our data suggest that the increase of AMH serum level in PCOS is the consequence of the androgen-induced excess in small antral FN and that each follicle produces a normal amount of AMH. We hypothesize that an increased AMH tone within the cohort could be involved in the follicular arrest of PCOS, by interacting negatively with FSH at the time of selection.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“AMH concentrations reflect ovarian reserve and are correlated with the number of growing follicles [149].”
From Polycystic Ovary Syndrome: Pathophysiology, Presentation, and Treatment With Emphasis on Adolescent Girls (2019) · cites this paper as [149]
Citations
Cites
Franks, S. (1995) · New England Journal of Medicine · doi:10.1056/nejm199509283331307 · Cited by 2,463
Serum anti-Müllerian hormone levels: a novel measure of ovarian reserve.
van Rooij, I., Broekmans, F., Velde, E. T., Fauser, B. C., Bancsi, L., de Jong, F. D., & Themmen, A. (2002) · Human Reproduction · doi:10.1093/humrep/17.12.3065 · Cited by 1,021
Antimüllerian hormone serum levels: a putative marker for ovarian aging
de Vet, A., Laven, J. S. E., de Jong, F. H., Themmen, A. P. N., & Fauser, B. C. J. M. (2002) · Fertility and Sterility · doi:10.1016/s0015-0282(01)02993-4 · Cited by 886
Anti-Mullerian Hormone Inhibits Initiation of Primordial Follicle Growth in the Mouse Ovary
Durlinger, A. L. L., Gruijters, M. J. G., Kramer, P., Karels, B., Ingraham, H. A., Nachtigal, M. W., Uilenbroek, J. T. J., Grootegoed, J. A., & Themmen, A. P. N. (2002) · Endocrinology · doi:10.1210/endo.143.3.8691 · Cited by 842
Anti-Mullerian Hormone Attenuates the Effects of FSH on Follicle Development in the Mouse Ovary
Durlinger, A. L. L., Gruijters, M. J. G., Kramer, P., Karels, B., Kumar, T. R., Matzuk, M. M., Rose, U. M., de Jong, F. H., Uilenbroek, J. T. J., Grootegoed, J. A., et al. (2001) · Endocrinology · doi:10.1210/endo.142.11.8486 · Cited by 772
Regulation of ovarian function: the role of anti-Mullerian hormone
Durlinger, A. L. L., Visser, J. A., & Themmen, A. P. N. (2002) · Reproduction · doi:10.1530/rep.0.1240601 · Cited by 766
Androgens stimulate early stages of follicular growth in the primate ovary
Vendola, K. A., Zhou, J., Adesanya, O. O., Weil, S. J., & Bondy, C. A. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2081 · Cited by 712
Fanchin, R., Schonauer, L. M., Righini, C., Guibourdenche, J., Frydman, R., & Taieb, J. (2003) · Human Reproduction · doi:10.1093/humrep/deg042 · Cited by 649
Estrogens inhibit and androgens enhance ovarian granulosa cell apoptosis.
Billig, H., Furuta, I., & Hsueh, A. J. W. (1993) · Endocrinology · doi:10.1210/endo.133.5.8404672 · Cited by 556
Seifer, D. B., MacLaughlin, D. T., Christian, B. P., Feng, B., & Shelden, R. M. (2002) · Fertility and Sterility · doi:10.1016/s0015-0282(01)03201-0 · Cited by 494
Flagged first, then by citations
Cited by
Sorted by citations
Items 301–400 of 709
The contribution of rare genetic variants to the pathogenesis of polycystic ovary syndrome
Dapas, M., & Dunaif, A. E. (2020) · Current Opinion in Endocrine and Metabolic Research · doi:10.1016/j.coemr.2020.02.011 · Cited by 28
Fábregues, F., Castelo-Branco, C., Carmona, F., Guimera, M., Casamitjana, R., & Balasch, J. (2011) · Gynecological Endocrinology · doi:10.3109/09513590.2010.487595 · Cited by 26
Saxena, R., Bjonnes, A., Georgopoulos, N. A., Koika, V., Panidis, D., & Welt, C. K. (2015) · Human Reproduction · doi:10.1093/humrep/dev110 · Cited by 26
Foroozanfard, F., Samimi, M., Almadani, K. H., & Sehat, M. (2017) · Electronic physician · doi:10.19082/5969 · Cited by 26
Anti-Müllerian Hormone and Ovarian Morphology in Women With Hypothalamic Hypogonadism
Alemyar, A., van der Kooi, A.-L., & Laven, J. S. E. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa116 · Cited by 26
Hoyos, L. R., Visser, J. A., McLuskey, A., Chazenbalk, G. D., Grogan, T., & Dumesic, D. A. (2020) · Human Reproduction · doi:10.1093/humrep/deaa199 · Cited by 26
Peigné, M., Simon, V., Pigny, P., Mimouni, N. E. H., Martin, C., Dewailly, D., Catteau-Jonard, S., & Giacobini, P. (2023) · Human Reproduction · doi:10.1093/humrep/dead050 · Cited by 27
Nawrocka-Rutkowska, J., Ciećwież, S. M., Marciniak, A., Brodowska, A., Wiśniewska, B., Kotlęga, D., & Starczewski, A. (2013) · PubMed · Cited by 26
Blauschmidt, S., Greither, T., Lampe, K., Köller, S., Kaltwaßer, P., & Behre, H. M. (2017) · Clinical Endocrinology · doi:10.1111/cen.13444 · Cited by 26
Tokmak, A., Kokanalı, D., Tımur, H., Kokanalı, M. K., & Yılmaz, N. (2016) · Gynecological Endocrinology · doi:10.1080/09513590.2016.1193140 · Cited by 25
Bhide, P., Kulkarni, A., Dilgil, M., Dhir, P., Shah, A. M., Gudi, A., & Homburg, R. (2017) · Gynecological Endocrinology · doi:10.1080/09513590.2017.1320377 · Cited by 24
Xu, G. Z., Zhang, A., Liu, J., Wang, X., Feng, J.-W., & Chen, Y. (2020) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2020/3608062 · Cited by 25
Madsen, H. N., Lauszus, F. F., Trolle, B., Ingerslev, H. J., & Tørring, N. (2015) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1111/aogs.12605 · Cited by 24
Prolactin in Polycystic Ovary Syndrome: Metabolic Effects and Therapeutic Prospects
Mastnak, L., Herman, R., Ferjan, S., Janež, A., & Jensterle, M. (2023) · Life · doi:10.3390/life13112124 · Cited by 30
Pabuçcu, R., Kaya, C., Çağlar, G. S., Öztaş, E., & Şatıroğlu, H. (2009) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2009.06.010 · Cited by 24
Predictive markers for the FSH sensitivity of women with polycystic ovarian syndrome
Köninger, A., Sauter, L., Edimiris, P., Kasimir‐Bauer, S., Kimmig, R., Strowitzki, T., & Schmidt, B. (2014) · Human Reproduction · doi:10.1093/humrep/det468 · Cited by 24
A contemporary view on global fertility, infertility, and assisted reproductive techniques
Barrera, N., Omolaoye, T. S., & du Plessis, S. S. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-818309-0.00009-5 · Cited by 25
PCOS: update and diagnostic approach
Goldrat, O., & Delbaere, A. (2018) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2018.09.001 · Cited by 24
Jacewicz‐Święcka, M., Wołczyński, S., & Kowalska, I. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10102101 · Cited by 23
Bell, R. J., Islam, R. M., Skiba, M. A., Herbert, D., García, A., & Davis, S. R. (2021) · Human Reproduction · doi:10.1093/humrep/deab232 · Cited by 23
Dysregulated Liver Metabolism and Polycystic Ovarian Syndrome
Khan, M. S., Kim, H., Kim, R., Yoon, S. H., & Kim, S. G. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24087454 · Cited by 26
Infertility Treatment in Polycystic Ovary Syndrome: Lifestyle Interventions, Medications and Surgery
Panidis, D., Τζιόμαλος, Κ., Papadakis, E. P., & Katsikis, I. (2012) · Frontiers of hormone research · doi:10.1159/000341824 · Cited by 25
Saikumar, P. (2013) · JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH · doi:10.7860/jcdr/2013/5530.3337 · Cited by 23
Nouri, M., Aghadavod, E., Khani, S., Jamilian, M., Siavashani, M. A., Ahmadi, S., & Asemi, Z. (2016) · Clinical Endocrinology · doi:10.1111/cen.13098 · Cited by 23
Anti-mullerian hormon level and polycystic ovarian syndrome diagnosis.
Zadehmodarres, S., Heidar, Z., Razzaghi, Z., Farsangi, L. E., Soltanzadeh, K., & Abed, F. (2015) · PubMed Central · Cited by 22
Carmina, E., Campagna, A. M., Mansuet, P., Vitale, G., Kort, D. H., & Lobo, R. A. (2012) · Fertility and Sterility · doi:10.1016/j.fertnstert.2012.06.017 · Cited by 22
Has GnRH a direct role in AMH regulation?
van Helden, J., Evliyaoğlu, O., & Weiskirchen, R. (2019) · Clinical Endocrinology · doi:10.1111/cen.13967 · Cited by 23
Bhide, P., Pundir, J., Gudi, A., Shah, A. J., Homburg, R., & Acharya, G. (2019) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1111/aogs.13625 · Cited by 22
Kaur, J., & Mahajan, N. (2019) · Journal of Human Reproductive Sciences · doi:10.4103/jhrs.jhrs_149_18 · Cited by 23
Assay reproducibility and within-person variation of Müllerian inhibiting substance
Dorgan, J. F., Spittle, C. S., Egleston, B. L., Shaw, C. M., Kahle, L., & Brinton, L. A. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2009.03.032 · Cited by 22
Anti-mullerian hormone: clinical relevance in assisted reproductive therapy
Fréour, T., Mirallié, S., Colombel, A., Bach‐Ngohou, K., Masson, D., & Barrière, P. (2006) · Annales d Endocrinologie · doi:10.1016/s0003-4266(06)73008-6 · Cited by 22
A specific immunoassay for proAMH, the uncleaved proprotein precursor of anti-Müllerian hormone
Pankhurst, M. W., & McLennan, I. S. (2015) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2015.10.013 · Cited by 21
Diminished Ovarian Reserve in Girls and Adolescents with Trisomy X Syndrome
Davis, S., Soares, K., Howell, S., Cree‐Green, M., Buyers, E. M., Johnson, J., & Tartaglia, N. R. (2020) · Reproductive Sciences · doi:10.1007/s43032-020-00216-4 · Cited by 23
Caanen, M. R., Peters, H. E., van de Ven, P. M., Jüttner, A. M. F. M., Laven, J. S. E., van Hooff, M. H. A., & Lambalk, C. B. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa949 · Cited by 21
Tsukui, Y., Kitahara, Y., Hasegawa, Y., Kobayashi, M., Osuka, S., & Iwase, A. (2022) · Endocrine Journal · doi:10.1507/endocrj.ej22-0081 · Cited by 23
Li, Y., Wei, L., & Liang, X. (2011) · Fertility and Sterility · doi:10.1016/j.fertnstert.2011.03.047 · Cited by 21
Hwang, Y. I., Sung, N., Koo, H. S., Cha, S. H., Park, C. W., Kim, J. Y., Yang, K. M., Song, I. O., Koong, M. K., Kang, I. S., et al. (2013) · Daehan saengsik uihak hoeji/Clinical and experimental reproductive medicine · doi:10.5653/cerm.2013.40.3.135 · Cited by 22
Bishop, C. V., Takahashi, D. L., Mishler, E., Slayden, O. D., Roberts, C. T., Hennebold, J. D., & True, C. A. (2020) · Human Reproduction · doi:10.1093/humrep/deaa321 · Cited by 20
Serum anti-Müllerian hormone as a predictive marker of polycystic ovarian syndrome
Parco, S. (2011) · International Journal of General Medicine · doi:10.2147/ijgm.s25639 · Cited by 21
Is There a Relationship Between Vitamin D Deficiency Status and PCOS in Infertile Women?
Arslan, E., Görkem, Ü., & Toğrul, C. (2019) · Geburtshilfe und Frauenheilkunde · doi:10.1055/a-0871-6831 · Cited by 21
Chun, S. (2015) · Gynecological Endocrinology · doi:10.3109/09513590.2015.1056143 · Cited by 20
Pavlik, R., Hecht, S., Ochsenkühn, R., Noss, U., Lohse, P., & Thaler, C. (2011) · Fertility and Sterility · doi:10.1016/j.fertnstert.2011.03.023 · Cited by 20
The role of mullerian inhibiting substance in female reproduction
Nakhuda, G. S. (2008) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/gco.0b013e3282fe99f2 · Cited by 20
Lamazou, F., Genro, V. K., Fuchs, F., Grynberg, M., Gallot, V., Frydman, N., Fanchin, R. R. F., & Frydman, R. (2011) · Journal de gynécologie, obstétrique et biologie de la reproduction. Supplément/Journal de gynécologie obstétrique et biologie de la reproduction · doi:10.1016/j.jgyn.2011.02.002 · Cited by 20
Knez, J., Kovačič, B., Medved, M., & Vlaisavljević, V. (2015) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-015-0049-5 · Cited by 19
Yu, K., Zhang, X., Tan, X., Ji, M., Chen, Y., Wan, Z., & Yu, Z. (2020) · Food and Chemical Toxicology · doi:10.1016/j.fct.2020.111309 · Cited by 19
AMH in PCOS: Controlling the ovary, placenta, or brain?
Moolhuijsen, L. M. E., & Visser, J. A. (2020) · Current Opinion in Endocrine and Metabolic Research · doi:10.1016/j.coemr.2020.04.006 · Cited by 20
Hyperandrogenism in Adolescent Girls
Cortet‐Rudelli, C., & Dewailly, D. (2004) · KARGER eBooks · doi:10.1159/000077083 · Cited by 19
Expression of anti-Müllerian hormone in letrozole rat model of polycystic ovary syndrome
Du, D., Li, X., Fang, F., & Du, M. (2014) · Gynecological Endocrinology · doi:10.3109/09513590.2014.943723 · Cited by 19
Peigné, M., Pigny, P., Pankhurst, M. W., Drumez, É., Loyens, A., Dewailly, D., Catteau-Jonard, S., & Giacobini, P. (2020) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2020.07.020 · Cited by 20
Lin, L., Li, C., & Tsui, K. (2021) · Scientific Reports · doi:10.1038/s41598-021-85915-x · Cited by 21
Luo, E., Zhang, J., Song, J., Feng, D., Meng, Y., Jiang, H., Li, D., & Fang, Y. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.659717 · Cited by 19
Garin, M. C., Butts, S. F., Sarwer, D. B., Allison, K. C., Senapati, S., & Dokras, A. (2016) · Endocrine · doi:10.1007/s12020-016-1210-4 · Cited by 20
Anti-Mullerian hormone and insulin resistance in polycystic ovary syndrome
Fonseca, H. P., Brondi, R. S., Piovesan, F. X., Miklos, T. G., & Aldrighi, J. M. (2014) · Gynecological Endocrinology · doi:10.3109/09513590.2014.920004 · Cited by 18
AMH after laparoscopic surgery of the ovaries: a review
Kalampokas, T., Kamath, M. S., & Kalampokas, E. (2013) · Gynecological Endocrinology · doi:10.3109/09513590.2012.754877 · Cited by 18
Detti, L., Fletcher, N. M., Saed, G. M., Peregrín-Álvarez, I., & Uhlmann, R. A. (2017) · Reproductive Sciences · doi:10.1177/1933719117737850 · Cited by 18
PCOS and peripheral AMH levels in relation to FSH receptor gene single nucleotide polymorphisms
Mohiyiddeen, L., Salim, S., Mulugeta, B., McBurney, H., Newman, W. G., Pemberton, P., & Nardo, L. G. (2012) · Gynecological Endocrinology · doi:10.3109/09513590.2011.633649 · Cited by 18
Tian, X., Ruan, X., Mueck, A. O., Wang, J., Liu, S., Yin, D., Lu, Y., Wu, H., & Zhang, Y. (2013) · Gynecological Endocrinology · doi:10.3109/09513590.2013.864273 · Cited by 18
Ageing and reproduction: is polycystic ovary syndrome an exception?
Vulpoi, C., Lecomte, C., Guilloteau, D., & Lecomte, P. (2007) · Annales d Endocrinologie · doi:10.1016/j.ando.2006.12.005 · Cited by 18
Wachs, D. S., Coffler, M. S., Malcom, P. J., & Chang, R. J. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0442 · Cited by 18
Vern-Gross, T. Z., Bradley, J. A., Rotondo, R. L., & Indelicato, D. J. (2015) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2015.10.001 · Cited by 18
Višňová, H., Papaleo, E., Martín, F. S., Koziol, K., Klein, B. M., & Mannaerts, B. M. J. L. (2021) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2021.08.024 · Cited by 17
He, Y., Li, X., Li, Y., Kuai, D., Zhang, H., Wang, Y., & Tian, W. (2024) · Steroids · doi:10.1016/j.steroids.2024.109424 · Cited by 17
Chronic anovulation and the polycystic ovary syndrome
KASE, N. G. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9781139003254.012 · Cited by 16
Jin, H., Shen, X., Song, W., Liu, Y., Qi, L., & Zhang, F. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.751373 · Cited by 17
Kedem, A., Hourvitz, A., Yung, Y., Shalev, L., Yerushalmi, G., Kanety, H., Hanochi, M., & Maman, E. (2013) · Gynecological Endocrinology · doi:10.3109/09513590.2013.798279 · Cited by 17
Şahmay, S., Güralp, O., Mathyk, B. A., Çepni, İ., Oral, E., & İrez, T. (2013) · Gynecological Endocrinology · doi:10.3109/09513590.2013.769519 · Cited by 17
Šunj, M., Canic, T., Jerončić, A., Karelović, D., Tandara, M., Petricevic, S. J., & Palada, I. (2014) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2014.05.011 · Cited by 17
Marsh, E. E., Bernardi, L. A., Steinberg, M. L., Chavez, P. J. D. D., Visser, J. A., Carnethon, M. R., & Baird, D. D. (2016) · Fertility and Sterility · doi:10.1016/j.fertnstert.2016.04.008 · Cited by 17
Utriainen, P., Jääskeläinen, J., & Voutilainen, R. (2010) · Hormone Research in Paediatrics · doi:10.1159/000282113 · Cited by 17
Karaviti, E., Karaviti, D., Kani, E.-R., Chatziandreou, E., Paschou, S. Α., Ψαλτοπούλου, Θ., Kalantaridou, S., & Lambrinoudaki, I. V. (2025) · Endocrine · doi:10.1007/s12020-025-04265-0 · Cited by 16
Mimouni, N. E. H., & Giacobini, P. (2024) · Comptes Rendus Biologies · doi:10.5802/crbiol.147 · Cited by 18
Özay, A. C., Özay, Ö. E., & Gülekli, B. (2020) · Ginekologia Polska · doi:10.5603/gp.a2020.0122 · Cited by 16
Anti-Müllerian Hormone in the Diagnosis and Prediction of Premature Ovarian Insufficiency
Anderson, R. A., & Nelson, S. M. (2020) · Seminars in Reproductive Medicine · doi:10.1055/s-0040-1722319 · Cited by 16
Talhouk, R., Tarraf, C. G., Kobrossy, L., Shaito, A., Bazzi, S. I., Bazzoun, D., & El-Sabban, M. E. (2012) · Europe PMC (PubMed Central) · Cited by 16
Singh, A. K., & Singh, R. (2015) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/2230-8210.167548 · Cited by 16
Erdeve, Ş. S., Keskın, M., Sağsak, E., Çenesiz, F., Çetinkaya, S. Ç., & Aycan, Z. (2016) · Hormone Research in Paediatrics · doi:10.1159/000446111 · Cited by 16
Editorial commentary: What's in a number? The polycystic ovary revisited
Raine‐Fenning, N. J. (2011) · Human Reproduction · doi:10.1093/humrep/der300 · Cited by 16
Chen, X., Hong, L., Diao, L., Yin, T., & Liu, S. (2024) · American Journal of Reproductive Immunology · doi:10.1111/aji.13854 · Cited by 17
Polycystic ovary syndrome: antimüllerian hormone and its role in the pathophysiology of the syndrome
Laven, J. S. E. (2025) · Fertility and Sterility · doi:10.1016/j.fertnstert.2025.08.023 · Cited by 19
Genomic analyses implicate hormonal and metabolic dysregulation in polycystic ovary syndrome
Moolhuijsen, L. M. E., Zhu, J., Mullin, B. H., Pujol‐Gualdo, N., Actkins, K. V., Mack, J. A., Rao, H., Trivedi, B., Kentistou, K. A., Zhao, Y., et al. (2026) · Nature Genetics · doi:10.1038/s41588-026-02543-9 · Cited by 30
Łebkowska, A., Adamska, A., Karczewska‐Kupczewska, M., Nikołajuk, A., Otziomek, E., Milewski, R. J., Górska, M., Wołczyński, S., & Kowalska, I. (2016) · Metabolism · doi:10.1016/j.metabol.2016.02.005 · Cited by 15
Two-sided role of estrogen on endometrial carcinogenesis: stimulator or suppressor?
Miyamoto, T., & Shiozawa, T. (2019) · Gynecological Endocrinology · doi:10.1080/09513590.2018.1549219 · Cited by 15
Use of AMH in the Differential Diagnosis of Anovulatory Disorders Including PCOS
Capuzzo, M., & Marca, A. L. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.616766 · Cited by 18
Du, M., Zhang, J., Yu, X., & Guan, Y. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.788000 · Cited by 15
Fine particulate matter and polycystic ovarian morphology
Fruh, V., Cheng, J. J., Aschengrau, A., Mahalingaiah, S., & Lane, K. J. (2022) · Environmental Health · doi:10.1186/s12940-022-00835-1 · Cited by 15
Anti-Mullerian hormone normogram in an Irish subfertile population
Naasan, M., Harrity, C., Pentony, L., & Mocanu, E. V. (2014) · Irish Journal of Medical Science (1971 -) · doi:10.1007/s11845-014-1089-0 · Cited by 15
Androgens and poor responders: are we ready to take the plunge into clinical therapy?
Fanchin, R. R. F., Frydman, N., Even, M., da Silva, A.-L. B., Grynberg, M., & Ayoubi, J.-M. (2011) · Fertility and Sterility · doi:10.1016/j.fertnstert.2011.09.050 · Cited by 15
Efthymiadou, A., Μπογιατζίδου, Μ., Kritikou, D., & Chrysis, D. (2018) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2018.09.064 · Cited by 15
Gözer, A., BAHAN, O., Doğruer, G., & Kutlu, T. (2023) · Theriogenology · doi:10.1016/j.theriogenology.2023.02.010 · Cited by 14
The Search for the Causes of Common Hyperandrogenism, 1965 to Circa 2015
Rosenfield, R. L. (2024) · Endocrine Reviews · doi:10.1210/endrev/bnae007 · Cited by 16
Utility of Serum Anti-Müllerian Hormone Measurement as Part of Polycystic Ovary Syndrome Diagnosis
Piltonen, T., Viita-aho, J., Saarela, U., Melin, J. M., & Forslund, M. (2024) · Seminars in Reproductive Medicine · doi:10.1055/s-0044-1786731 · Cited by 19
Şahmay, S., Güralp, O., Senturk, L. M., İmamoğlu, M., Küçük, M., & İrez, T. (2011) · Reproductive Medicine and Biology · doi:10.1007/s12522-011-0078-5 · Cited by 14
Vural, F., Vural, B., Kardas, E., Coşkun, A. D. E., & Yildirim, İ. (2022) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-022-06874-w · Cited by 14
Mahran, A. (2015) · Middle East Fertility Society Journal · doi:10.1016/j.mefs.2015.06.003 · Cited by 14
Gerli, S., Favilli, A., Brozzetti, A., Torlone, E., Pugliese, B., Pericoli, S., Bini, V., & Falorni, A. (2014) · Endocrine · doi:10.1007/s12020-014-0515-4 · Cited by 14
Lan, K., Chang, S., Huang, F.-J., Lin, H.-J., Lin, C., Huang, K., & Kang, H. (2013) · Reproductive Biology and Endocrinology · doi:10.1186/1477-7827-11-11 · Cited by 14
Paramu, S. (2016) · Journal of Turkish Society of Obstetric and Gynecology · doi:10.4274/tjod.97523 · Cited by 14
Zhu, J., Li, T., Xing, W., Lin, H., & Ou, J. (2018) · Gynecological Endocrinology · doi:10.1080/09513590.2018.1462317 · Cited by 14
Barbagallo, F., van der Ham, K., Willemsen, S. P., Louwers, Y. V., & Laven, J. S. E. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae153 · Cited by 13
Metadata
- Authors
- Pigny, P., Merlen, E., Robert, Y., Cortet-Rudelli, C., Decanter, C., Jonard, S., & Dewailly, D.
- Affiliations
- Laboratory of Endocrinology (P.P.), 59037 Lille, France;
- Clinique Marc Linquette; Departments of Endocrine Gynaecology and Reproductive Medicine (E.M., C.D., S.J., D.D.), 59037 Lille, France;
- Hôpital Jeanne de Flandre (FR)
- Department of Diabetology and Endocrinology (C.C.-R.), Centre Hospitalier Régional Universitaire de Lille, 59037 Lille, France
- Corresponding author
- Dewailly, Didier
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2003-12-01
- Volume
- 88
- Issue
- 12
- Pages
- 5957-5962
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2153731002
- Cited by
- 709
- References
- 28
- Citations by year
- 2026: 18 · 2025: 20 · 2024: 34 · 2023: 25 · 2022: 45 · 2021: 45 · 2020: 30 · 2019: 41 · 2018: 38 · 2017: 37 · 2016: 47 · 2015: 33 · 2014: 37 · 2013: 43 · 2012: 38
- FWCI
- 10.40
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Reproductive Medicine › Reproductive Biology and Fertility
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
- Keywords
- anti-Müllerian hormone, polycystic ovary syndrome, antral follicle count, follicle-stimulating hormone, testosterone, androstenedione, granulosa cells, ovarian reserve, folliculogenesis, ovarian ultrasonography, inhibin B, estradiol, luteinizing hormone, progestins
- MeSH terms
- Adult, Female, Glycoproteins, Ovarian Follicle, Hormones, Humans, Immunoassay, Obesity, Polycystic Ovary Syndrome, Testicular Hormones, Ultrasonography, Case-Control Studies, Anti-Mullerian Hormone
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review